AE
At a glance
Registered since
2024
Senate LDA system
Clients
2
last 3 years
Filings
4
3 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Health Policy Coordinator
Energy and Commerce Committee; Health Policy Advisor, Health Subcommittee
Chairman Bilirakis
Disclosed on LD-2 filings
Career
AL
Specific issues
ADHD treatment. Implementation of the Infrastructure Investment and Jobs Act (or bipartisan infrastructure law). Traffic safety (distracted and impaired driving).
General health care issues.
PBM reforms. 340B. IRA implementation. Drug pricing. H.R.5378 - Lower Costs, More Transparency Act. H.R.5376 - Share the Savings with Seniors Act. H.R.6283/S.1542 - DRUG Act. H.R.2880 - Protecting Patients Against PBM Abuses Act. S.2973 - Modernizing and Ensuring PBM Accountability Act. H.R.830 - HELP Copays Act. H.R.7085 - BIOSECURE Act. S.127 - Pharmacy Benefit Manager Transparency Act of 2023. S.1339 - Pharmacy Benefit Manager Reform Act H.R.3290 - To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
PBM reforms. 340B. IRA implementation. Drug pricing. General health care issues.
Clients
Filing history
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS